Skip to main content
logo
SEB SA (FRA:GRB)
Germany flag Germany · Delayed Price · Currency is EUR
66.50
-0.45 (-0.67%)
At close: Jul 29, 2025, 10:00 PM CET

Intra-Cellular Therapies Revenue

SEB SA had revenue of 3.75B EUR in the half year ending June 30, 2025, with 3.76% growth. This brings the company's revenue in the last twelve months to 8.27B, up 1.71% year-over-year. In the year 2024, SEB SA had annual revenue of 8.27B with 3.25% growth.

Revenue (ttm)
8.27B
Revenue Growth
+1.71%
P/S Ratio
0.41
Revenue / Employee
258.55K
Employees
32,237
Market Cap
3.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.27B260.00M3.25%
Dec 31, 20238.01B46.30M0.58%
Dec 31, 20227.96B-99.10M-1.23%
Dec 31, 20218.06B1.12B16.12%
Dec 31, 20206.94B-413.90M-5.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SAP SE35.89B
Siemens Aktiengesellschaft77.82B
Deutsche Telekom AG120.25B
Allianz SE109.03B
Siemens Energy AG37.44B
Rheinmetall AG10.48B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München61.84B
Deutsche Bank Aktiengesellschaft30.07B
Revenue Rankings

SEB SA News

More News